Xilio Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ADAG
Adagene Inc. |
$1.58 | $57.29 M | -2.05 | 138 |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.06 | $43.55 M | -3.66 | 2 |
![]() ANTX
AN2 Therapeutics, Inc. |
$1.26 | $37.77 M | -0.73 | 22 |
![]() AVTE
Aerovate Therapeutics, Inc. |
$2.69 | $77.97 M | -1.1 | 30 |
![]() CNTB
Connect Biopharma Holdings Limited |
$0.84 | $46.68 M | -3.01 | 62 |
![]() CSBR
Champions Oncology, Inc. |
$8.26 | $114.14 M | 18.34 | 210 |
![]() CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 |
![]() DSGN
Design Therapeutics, Inc. |
$3.39 | $192.43 M | -3.85 | 54 |
![]() ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$13.03 | $1.37 B | -8.99 | 110 |
![]() IKNA
Ikena Oncology, Inc. |
$1.11 | $44.69 M | -1.09 | 10 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.52 | $877.13 M | -3.69 | 51 |
![]() MNOV
MediciNova, Inc. |
$1.46 | $71.61 M | -6.35 | 13 |
![]() MOLN
Molecular Partners AG |
$3.57 | $131.64 M | -1.84 | 158 |
![]() RAPT
RAPT Therapeutics, Inc. |
$0.80 | $105.62 M | -0.25 | 68 |
![]() TYRA
Tyra Biosciences, Inc. |
$8.61 | $436.96 M | -5.7 | 60 |